Literature DB >> 25365109

BIOBADASER, BIOBADAMERICA, and BIOBADADERM: safety registers sharing commonalities across diseases and countries.

L Carmona1, M de la Vega, R Ranza, G Casado, D C Titton, M Á Descalzo, Juan Gómez-Reino.   

Abstract

Registers facilitate the collection and communication of safety concerns. There are as many different register structures as registers, making the merging of rare data and comparison between registers difficult. BIOBADASER, the Safety Register of the Spanish Society of Rheumatology has served as template for other registers within the specialty, BIOBADAMERICA, and outside rheumatology, BIOBADADERM. Here we present the limitations and strengths of such template registers.

Mesh:

Substances:

Year:  2014        PMID: 25365109

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  5 in total

1.  Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR.

Authors:  Roberto Ranza; Maria Celina de la Vega; Ieda Maria Magalhães Laurindo; Marìa Gimena Gómez; David Cezar Titton; Adriana Maria Kakehasi; Alejandro Brigante; Alejandro Benitez; Aline Ranzolin; Amelia Granel; Ana María Cappuccio; Ana Quinteros; André Luiz Shinji Hayata; Andrea Smichowski; Ângela Luzia Branco P Duarte; Barbara Stadler Kahlow; Carolina Sánchez Andia; Claiton Viegas Brenol; Edson Velozo; Eduardo Mussano; Enrique R Soriano; Georges Basile Christopoulos; Geraldo da Rocha Castelar Pinheiro; Gláucio Ricardo Werner de Castro; Gustavo Casado; Hellen Mary da Silveira Carvalho; Ida Elena Exeni; Inês Guimarães da Silveira; Ingrid Petkovic; Ivanio Alves Pereira; Izaias Pereira da Costa; Javier Eduardo Rosa; José Roberto Silva Miranda; Julio Cesar Bertacini de Moraes; Manoel Barros Bertolo; Manuel Buhl; Maria Alícia Lázaro; Maria de Fátima Lobato C da Sauma; Marcelo de Medeiros Pinheiro; Monica Díaz; Mônica Valéria Siqueira Santana de Vechi; Osvaldo Luis Cerda; Pablo Astesana; Pablo Finucci Curi; Paulo Louzada-Jr; Reginaldo Botelho Teodoro; Roberto Acayaba Toledo; Sílvia Papasidero; Valeria Valim; Vander Fernandes; Veronica Saurit; Washington Alves Bianchi; Rogério de Melo Costa Pinto; Miguel Angel Descalzo; Juan Jesus Gomez-Reino
Journal:  Clin Rheumatol       Date:  2019-04-17       Impact factor: 2.980

2.  Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).

Authors:  P S Rommer; T Dörner; K Freivogel; J Haas; B C Kieseier; T Kümpfel; F Paul; F Proft; H Schulze-Koops; E Schmidt; H Wiendl; U Ziemann; U K Zettl
Journal:  J Neuroimmune Pharmacol       Date:  2015-11-20       Impact factor: 4.147

Review 3.  Barriers towards effective pharmacovigilance systems of biosimilars in rheumatology: A Latin American survey.

Authors:  Gilberto Castañeda-Hernández; Hugo Sandoval; Javier Coindreau; Luis Felipe Rodriguez-Davison; Carlos Pineda
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-05-30       Impact factor: 2.890

4.  Incidence of Infectious Adverse Events in Patients With Rheumatoid Arthritis and Spondyloarthritis on Biologic Drugs-Data From the Brazilian Registry for Biologics Monitoring.

Authors:  Mariana Cecconi; Roberto Ranza; David C Titton; Júlio C B Moraes; Manoel Bertolo; Washington Bianchi; Claiton Brenol; Hellen M Carvalho; Glaucio R W de Castro; Izaias P Costa; Maria F L Cunha; Ângela Duarte; Vander Fernandes; Marlene Freire; Paulo Louzada-Junior; José C Macieira; José R S Miranda; Ivanio A Pereira; Geraldo R C Pinheiro; Barbara Stadler; Roberto A Toledo; Valeria Valim; Miguel A Descalzo; Rogerio M C Pinto; Ieda Laurindo
Journal:  J Clin Rheumatol       Date:  2020-03       Impact factor: 3.517

5.  Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER.

Authors:  Juan José Bethencourt Baute; Carlos Sanchez-Piedra; Dolores Ruiz-Montesinos; Marta Medrano San Ildefonso; Carlos Rodriguez-Lozano; Eva Perez-Pampin; Ana Ortiz; Sara Manrique; Rosa Roselló; Victoria Hernandez; Cristina Campos; Agustí Sellas; Walter Alberto Sifuentes-Giraldo; Javier García-González; Fernando Sanchez-Alonso; Federico Díaz-González; Juan Jesús Gómez-Reino; Sagrario Bustabad Reyes
Journal:  Arthritis Res Ther       Date:  2018-10-10       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.